Market Research Logo

Soft Tissue Repair Global Market - Forecast to 2023

Soft Tissue Repair Global Market - Forecast to 2023

Muscles, ligaments, tendons, fat and connective tissue constitutes soft tissue, where as Bones, cartilage and dental enamel is considered to be hard tissues. Damage to these Soft tissues are repaired by procedures that include hernia repair, cardiac repair, breast reconstruction, dental reconstruction, skin repair, etc. It does not include procedures that involve whole organ transplant and tissue regeneration and consist of products that are essential for patients suffering with soft tissue injuries and damage. With the projected rise in aged population, sports injuries and increased number of medical procedures such as hernia repair, cardiac repair, vaginal sling procedures, dental reconstruction, skin repair, etc. The market is focused on growing with newer technology and improved products. According to IQ4I analysis, the soft tissue repair global market is expected to grow at high single digit CAGR reach $21,319.7 million by 2023. Factors driving the soft tissue repair market include, increase in aging population, increase in medical procedures and sports injuries along with technology advancements and growing investment potential in emerging markets are contributing to the growth of soft tissue repair global market. Lack of awareness, limited reimbursements and high cost of procedures are hampering the market growth. Advancement of technology with its wide application areas shows that soft tissue repair market has vast opportunities in the coming years.

Soft tissue repair global market is classified based on products, surgeries, applications, and geography. The products segment is divided into four segments i.e., meshes/tissue patches, fixation devices, cardiac repair devices and others. Where, the meshes/tissue patches are further classified into synthetic meshes (absorbable meshes and non-absorbable meshes) and biological meshes (allografts tissue patches and Xenograft). The fixation devices market included products such as suture anchors, interference screws and others. The cardiac repair devices market included products such as heart valves (mechanical heart valve, biologic heart valve) and others. While, the others market includes products such as cornea, otologic grafts, cardiac grafts and tendons and ligament grafts. Soft tissue repair market based on surgery is classified into open surgery and minimally invasive surgery (laparoscopy, arthroscopy, catheter based surgery and robotic surgery).

Based on application, the soft tissue repair products are segmented into hernia repair, dental reconstruction, vaginal sling procedure, skin repair, breast reconstruction, orthopedic (dural repair and sports medicine), cardiac repair (transcatheter aortic valve replacement, mechanical heart valve replacement, biological heart valve replacement, annuloplasty ring, MitraClip, occluders, stent grafts and cardiac tissue patches).

Based on geography soft tissue repair global market is classified as North America, Europe, Asia Pacific and Rest of the world. North America accounts for the highest market share followed by Europe. The steep rise in aging population, increase in medical procedures and sports injuries along with technology advancements and growing investment potential in emerging markets are driving factors of soft tissue repair products market. However, Asian countries especially China and India are the fastest growing regions with its growing demand for soft tissue repair products.

Major players in soft tissue repair market include Edwards Lifesciences (U.S.), Medtronic PLC (Ireland), Abbott Laboratories (U.S.), Arthrex Inc (U.S.), Johnson & Johnson (U.S.), C.R. Bard Inc, (U.S.), Allergan (Lifecell) (U.S.), Smith & Nephew (U.K.), Integra Lifesciences (U.S.), Livanova (U.K.), Zimmer Biomet (U.S.), Organogenesis (U.S.), etc.

The report provides an in-depth market analysis of the above-mentioned segments across the following regions:

North America

  • U.S.
  • Others
Europe
  • Germany
  • U.K.
  • France
  • Others
Asia-Pacific
  • Japan
  • China
  • India
  • Others
Rest of the World (RoW)
  • Brazil
  • Rest of Latin America
  • Middle-East and Others


1 EXECUTIVE SUMMARY
2 INTRODUCTION
2.1 KEY TAKEAWAYS
2.2 REPORT DESCRIPTION
2.3 MARKETS COVERED
2.4 STAKEHOLDERS
2.5 RESEARCH METHODOLOGY
2.5.1 MARKET SIZE ESTIMATION
2.5.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5.3 SECONDARY SOURCES
2.5.4 PRIMARY SOURCES
2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES
2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.5.7 ASSUMPTIONS
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.3.1 DRIVERS AND OPPORTUNITIES
3.3.1.1 Increased incidents of soft tissue injuries
3.3.1.2 Rise in ageing population
3.3.1.3 Technological advancements
3.3.1.4 Increase in investments and growth in emerging markets.
3.3.2 RESTRAINS AND THREATS
3.3.2.1 Lack of awareness
3.3.2.2 Limited reimbursement
3.3.2.3 High cost of products
3.3.2.4 Strict regulations
3.4 REGULATORY AFFAIRS
3.4.1 U.S.
3.4.2 EUROPE
3.4.3 CHINA
3.4.4 INDIA
3.4.5 JAPAN
3.4.6 AUSTRALIA
3.5 REIMBURSEMENT SCENARIO
3.6 PATENT ANALYSIS
3.7 TECHNOLOGY ADVANCEMENTS
3.7.1 IMPLANT DESIGN
3.7.2 BIOMATERIAL ADVANCEMENTS
3.8 FUNDING SCENARIO
3.9 SOFT TISSUE REPAIR PRODUCTS - DEALS
3.10 UPCOMING TECHNOLOGY AND PRODUCT LAUNCH
3.11 CLINICAL TRIALS
3.12 PORTER’S FIVE FORCE ANALYSIS
3.12.1 THREAT OF NEW ENTRANTS
3.12.2 THREAT OF SUBSTITUTES
3.12.3 BARGAINING POWER OF SUPPLIERS
3.12.4 BARGAINING POWER OF BUYERS
3.12.5 COMPETITIVE RIVALRY
3.13 SUPPLY CHAIN ANALYSIS
3.13.1 RAW MATERIAL SUPPLIER:
3.13.2 ORIGINAL EQUIPMENT MANUFACTURERS (OEM):-
3.13.3 PRODUCT MANUFACTURERS:-
3.13.4 SOFT TISSUE REPAIR PRODUCTS DISTRIBUTORS:
3.13.5 END-USERS
3.14 MARKET SHARE ANALYSIS
4 SOFT TISSUE REPAIR GLOBAL MARKET, BY PRODUCTS
4.1 INTRODUCTION
4.2 MESH/TISSUE PATCHES
4.2.1 SYNTHETIC MESHES
4.2.1.1 Absorbable meshes
4.2.1.2 Non-absorbable meshes
4.2.2 BIOLOGICAL MESHES
4.2.2.1 Allograft
4.2.2.2 Xenograft
4.3 FIXATION DEVICES
4.3.1 SUTURE ANCHORS
4.3.2 INTERFERENCE SCREWS
4.3.3 OTHER FIXATION DEVICES
4.4 CARDIAC REPAIR DEVICES
4.4.1 HEART VALVES
4.4.1.1 Mechanical heart valves
4.4.1.2 Biological heart valves (tissue valves)
4.4.2 OTHER CARDIAC REPAIR DEVICES
4.5 OTHERS
4.5.1 CORNEAL TRANSPLANTATION
4.5.2 OTOLOGIC GRAFT
4.5.3 CARDIAC GRAFTS
4.5.4 TENDONS AND LIGAMENT GRAFTS
5 SOFT TISSUE REPAIR GLOBAL MARKET, BY SURGERY
5.1 INTRODUCTION
5.2 OPEN SURGERY
5.3 MINIMALLY INVASIVE SURGERY
5.3.1 LAPAROSCOPIC SURGERY
5.3.2 ARTHROSCOPIC SURGERY
5.3.3 CATHETER-BASED SURGERY
5.3.4 ROBOTIC SURGERY
6 SOFT TISSUE REPAIR GLOBAL MARKET, BY APPLICATION
6.1 INTRODUCTION
6.2 HERNIA REPAIR
6.2.1 INGUINAL HERNIA REPAIR
6.2.2 INCISIONAL HERNIA REPAIR
6.2.3 UMBILICAL HERNIA REPAIR
6.2.4 OTHER HERNIA REPAIRS
6.3 DENTAL RECONSTRUCTION
6.4 VAGINAL SLINGS
6.5 SKIN REPAIR
6.6 BREAST RECONSTRUCTION
6.7 ORTHOPEDIC
6.7.1 DURAL REPAIR
6.7.2 SPORTS MEDICINE
6.7.2.1 Anterior Cruciate Ligament (ACL) repair
6.7.2.2 Rotator cuff repair
6.7.2.3 Achilles Tendon Repair
6.7.2.4 Other repairs
6.8 CARDIAC REPAIR
6.8.1 TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR)
6.8.2 MECHANICAL HEART VALVES REPLACEMENT
6.8.3 BIOLOGICAL HEART VALVE REPLACEMENT
6.8.4 ANNULOPLASTY RING
6.8.5 MITRACLIP
6.8.6 OCCLUDERS
6.8.7 STENT GRAFTS AND CARDIAC TISSUE PATCHES
6.9 OTHER SOFT TISSUE REPAIRS
7 SOFT TISSUE REPAIR MARKET, BY REGION
7.1 INTRODUCTION
7.2 NORTH AMERICA
7.2.1 U.S.
7.2.2 OTHERS
7.3 EUROPE
7.3.1 GERMANY
7.3.2 FRANCE
7.3.3 U.K.
7.3.4 OTHERS
7.4 ASIA-PACIFIC
7.4.1 JAPAN
7.4.2 CHINA
7.4.3 INDIA
7.4.4 OTHERS
7.5 ROW
7.5.1 BRAZIL
7.5.2 REST OF LATIN AMERICA
7.5.3 MIDDLE EAST & OTHERS
8 COMPETITIVE LANDSCAPE
8.1 INTRODUCTION
8.2 APPROVALS
8.3 ACQUISITIONS & MERGERS
8.4 NEW PRODUCT LAUNCHES
8.5 AGREEMENTS
8.6 OTHER STRATEGIES
9 MAJOR COMPANIES
9.1 ABBOTT LABORATORIES
9.1.1 OVERVIEW
9.1.2 FINANCIALS
9.1.3 PRODUCT PORTFOLIO
9.1.4 KEY DEVELOPMENTS
9.1.5 BUSINESS STRATEGY
9.1.6 SWOT ANALYSIS
9.2 ACELITY L.P. INC (ALLERGAN)
9.2.1 OVERVIEW
9.2.2 FINANCIALS
9.2.3 PRODUCT PORTFOLIO
9.2.4 KEY DEVELOPMENTS
9.2.5 BUSINESS STRATEGY
9.2.6 SWOT ANALYSIS
9.3 ARTHREX INC.
9.3.1 OVERVIEW
9.3.2 FINANCIALS
9.3.3 PRODUCT PORTFOLIO
9.3.4 KEY DEVELOPMENTS
9.3.5 BUSINESS STRATEGY
9.3.6 SWOT ANALYSIS
9.4 C.R.BARD INC.
9.4.1 OVERVIEW
9.4.2 FINANCIALS
9.4.3 PRODUCT PORTFOLIO
9.4.4 KEY DEVELOPMENTS
9.4.5 BUSINESS STRATEGY
9.4.6 SWOT ANALYSIS
9.5 EDWARDS LIFESCIENCES CORP.
9.5.1 OVERVIEW
9.5.2 FINANCIALS
9.5.3 PRODUCT PORTFOLIO
9.5.4 KEY DEVELOPMENTS
9.5.5 BUSINESS STRATEGY
9.5.6 SWOT ANALYSIS
9.6 INTEGRA LIFESCIENCES CORPORATION
9.6.1 OVERVIEW
9.6.2 FINANCIALS
9.6.3 PRODUCT PORTFOLIO
9.6.4 KEY DEVELOPMENTS
9.6.5 BUSINESS STRATEGY
9.6.6 SWOT ANALYSIS
9.7 JOHNSON & JOHNSON
9.7.1 OVERVIEW
9.7.2 FINANCIALS
9.7.3 PRODUCT PORTFOLIO
9.7.4 KEY DEVELOPMENTS
9.7.5 BUSINESS STRATEGY
9.7.6 SWOT ANALYSIS
9.8 LIVANOVA, PLC
9.8.1 OVERVIEW
9.8.2 FINANCIALS
9.8.3 PRODUCT PORTFOLIO
9.8.4 KEY DEVELOPMENTS
9.8.5 BUSINESS STRATEGY
9.8.6 SWOT ANALYSIS
9.9 MEDTRONIC, PLC
9.9.1 OVERVIEW
9.9.2 FINANCIALS
9.9.3 PRODUCT PORTFOLIO
9.9.4 KEY DEVELOPMENTS
9.9.5 BUSINESS STRATEGY
9.9.6 SWOT ANALYSIS
9.10 ORGANOGENESIS, INC.
9.10.1 OVERVIEW
9.10.2 FINANCIALS
9.10.3 PRODUCT PORTFOLIO
9.10.4 KEY DEVELOPMENTS
9.10.5 BUSINESS STRATEGY
9.10.6 SWOT ANALYSIS
9.11 SMITH & NEPHEW, PLC
9.11.1 OVERVIEW
9.11.2 FINANCIALS
9.11.3 PRODUCT PORTFOLIO
9.11.4 KEY DEVELOPMENTS
9.11.5 BUSINESS STRATEGY
9.11.6 SWOT ANALYSIS
9.12 ZIMMER BIOMET HOLDINGS, INC
9.12.1 OVERVIEW
9.12.2 FINANCIALS
9.12.3 PRODUCT PORTFOLIO
9.12.4 KEY DEVELOPMENTS
9.12.5 BUSINESS STRATEGY
9.12.6 SWOT ANALYSIS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report